nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—TNF—vagina—polycystic ovary syndrome	0.0217	0.223	CbGeAlD
Amrinone—PDE3A—adipose tissue—polycystic ovary syndrome	0.00926	0.0952	CbGeAlD
Amrinone—PDE3A—adrenal gland—polycystic ovary syndrome	0.00831	0.0854	CbGeAlD
Amrinone—PDE3A—female gonad—polycystic ovary syndrome	0.00775	0.0796	CbGeAlD
Amrinone—PDE4B—endometrium—polycystic ovary syndrome	0.00741	0.0761	CbGeAlD
Amrinone—PDE3A—endocrine gland—polycystic ovary syndrome	0.0072	0.074	CbGeAlD
Amrinone—PDE4B—pituitary gland—polycystic ovary syndrome	0.0067	0.0689	CbGeAlD
Amrinone—PDE4B—adipose tissue—polycystic ovary syndrome	0.00668	0.0686	CbGeAlD
Amrinone—PDE4B—adrenal gland—polycystic ovary syndrome	0.00599	0.0615	CbGeAlD
Amrinone—PDE4B—female gonad—polycystic ovary syndrome	0.00558	0.0574	CbGeAlD
Amrinone—PDE4B—vagina—polycystic ovary syndrome	0.00555	0.057	CbGeAlD
Amrinone—PDE4B—endocrine gland—polycystic ovary syndrome	0.00519	0.0534	CbGeAlD
Amrinone—TNF—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00189	0.00209	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00185	0.00205	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00185	0.00205	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—POMC—polycystic ovary syndrome	0.00185	0.00205	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00184	0.00203	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00184	0.00203	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—PPARG—polycystic ovary syndrome	0.00184	0.00203	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TNFSF10—polycystic ovary syndrome	0.00183	0.00203	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00181	0.00201	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00181	0.002	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00179	0.00199	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—BCL2—polycystic ovary syndrome	0.00179	0.00199	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—TAB1—polycystic ovary syndrome	0.00178	0.00197	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.00175	0.00194	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.00175	0.00194	CbGpPWpGaD
Amrinone—TNF—IL27-mediated signaling events—IL6—polycystic ovary syndrome	0.00174	0.00193	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00174	0.00192	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—SERPINE1—polycystic ovary syndrome	0.00173	0.00192	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00172	0.0019	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00172	0.0019	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—polycystic ovary syndrome	0.0017	0.00188	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.00169	0.00187	CbGpPWpGaD
Amrinone—TNF—Cytokines and Inflammatory Response—IL6—polycystic ovary syndrome	0.00169	0.00187	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00167	0.00185	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00167	0.00185	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00167	0.00185	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00163	0.00181	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00162	0.0018	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.00159	0.00176	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00159	0.00176	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00159	0.00176	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00159	0.00176	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—NCOR1—polycystic ovary syndrome	0.00156	0.00173	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00156	0.00173	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00154	0.00171	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00154	0.00171	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TAB1—polycystic ovary syndrome	0.00153	0.0017	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00151	0.00168	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—polycystic ovary syndrome	0.00151	0.00167	CbGpPWpGaD
Amrinone—TNF—Apoptosis—IGF1—polycystic ovary syndrome	0.00151	0.00167	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—AKT2—polycystic ovary syndrome	0.0015	0.00167	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.0015	0.00166	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00148	0.00164	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00148	0.00163	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00147	0.00163	CbGpPWpGaD
Amrinone—TNF—amb2 Integrin signaling—IL6—polycystic ovary syndrome	0.00147	0.00163	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—NR3C1—polycystic ovary syndrome	0.00144	0.0016	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00144	0.0016	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.0014	0.00156	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.0014	0.00155	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.00139	0.00154	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.00138	0.00153	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00135	0.0015	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00134	0.00149	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00134	0.00148	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BAX—polycystic ovary syndrome	0.00132	0.00146	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2—polycystic ovary syndrome	0.00131	0.00146	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.00131	0.00145	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IRS2—polycystic ovary syndrome	0.00131	0.00145	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—IL6—polycystic ovary syndrome	0.00131	0.00145	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.00129	0.00143	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—LEP—polycystic ovary syndrome	0.00128	0.00142	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00128	0.00142	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00128	0.00142	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00127	0.00141	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.00125	0.00138	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00123	0.00136	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PLAT—polycystic ovary syndrome	0.00122	0.00135	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00122	0.00135	CbGpPWpGaD
Amrinone—TNF—TWEAK Signaling Pathway—IL6—polycystic ovary syndrome	0.00118	0.00131	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00118	0.00131	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NPB—polycystic ovary syndrome	0.00118	0.00131	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00117	0.0013	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00117	0.0013	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00116	0.00129	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IRS1—polycystic ovary syndrome	0.00115	0.00127	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00114	0.00127	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.00113	0.00125	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NPB—polycystic ovary syndrome	0.00112	0.00124	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—PPARG—polycystic ovary syndrome	0.00112	0.00124	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.00112	0.00124	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00112	0.00124	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00111	0.00123	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—INS—polycystic ovary syndrome	0.0011	0.00122	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.0011	0.00121	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00109	0.0012	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00107	0.00119	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00107	0.00118	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.00106	0.00118	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00106	0.00118	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IGF1—polycystic ovary syndrome	0.00106	0.00118	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00105	0.00116	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00104	0.00115	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00104	0.00115	CbGpPWpGaD
Amrinone—TNF—Allograft Rejection—VEGFA—polycystic ovary syndrome	0.00103	0.00114	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00102	0.00113	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00102	0.00112	CbGpPWpGaD
Amrinone—TNF—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.00101	0.00112	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00101	0.00112	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—SERPINE1—polycystic ovary syndrome	0.00101	0.00112	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.00101	0.00111	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000995	0.0011	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000994	0.0011	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000987	0.00109	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000985	0.00109	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000985	0.00109	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000949	0.00105	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000946	0.00105	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—GNAS—polycystic ovary syndrome	0.000938	0.00104	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000937	0.00104	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000937	0.00104	CbGpPWpGaD
Amrinone—TNF—Apoptosis—AKT2—polycystic ovary syndrome	0.000921	0.00102	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000921	0.00102	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000903	0.001	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000895	0.000991	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000876	0.000971	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00087	0.000964	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—AKT2—polycystic ovary syndrome	0.000864	0.000957	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000851	0.000943	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000848	0.000939	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000828	0.000917	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—IL6—polycystic ovary syndrome	0.000825	0.000914	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000807	0.000894	CbGpPWpGaD
Amrinone—TNF—Apoptosis—BCL2—polycystic ovary syndrome	0.000805	0.000892	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000792	0.000877	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.00078	0.000864	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000772	0.000855	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000753	0.000834	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000734	0.000813	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000721	0.000799	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—DLG4—polycystic ovary syndrome	0.000716	0.000794	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000711	0.000787	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000701	0.000777	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000686	0.00076	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000681	0.000755	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000678	0.000751	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IL6—polycystic ovary syndrome	0.000672	0.000745	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000671	0.000744	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000667	0.000739	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000659	0.000731	CbGpPWpGaD
Amrinone—TNF—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000655	0.000726	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000645	0.000714	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FST—polycystic ovary syndrome	0.000643	0.000712	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000639	0.000708	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000635	0.000703	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—IL6—polycystic ovary syndrome	0.000632	0.0007	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000627	0.000695	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000627	0.000695	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000613	0.000679	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FST—polycystic ovary syndrome	0.000611	0.000677	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000608	0.000673	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—IGF1—polycystic ovary syndrome	0.000607	0.000673	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—AKT2—polycystic ovary syndrome	0.000607	0.000672	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000604	0.000669	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000599	0.000664	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000597	0.000661	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000594	0.000658	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000593	0.000656	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000588	0.000651	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000583	0.000646	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.000582	0.000645	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.00058	0.000643	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000577	0.000639	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000565	0.000626	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000564	0.000624	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000561	0.000621	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000559	0.000619	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000552	0.000611	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000551	0.00061	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000546	0.000605	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000538	0.000596	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000537	0.000594	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000533	0.000591	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000524	0.000581	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.00052	0.000576	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000518	0.000574	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000512	0.000567	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00051	0.000565	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.00051	0.000565	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000503	0.000557	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000485	0.000538	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000481	0.000533	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—IL6—polycystic ovary syndrome	0.00048	0.000531	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000479	0.00053	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000458	0.000507	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000457	0.000506	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.000455	0.000504	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.00045	0.000499	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000445	0.000493	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—LEP—polycystic ovary syndrome	0.000442	0.000489	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000435	0.000482	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000428	0.000474	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000424	0.000469	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000414	0.000459	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000414	0.000459	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000414	0.000459	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000399	0.000442	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—VEGFA—polycystic ovary syndrome	0.000397	0.000439	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000395	0.000438	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000394	0.000436	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000394	0.000436	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000385	0.000427	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—PPARG—polycystic ovary syndrome	0.000385	0.000426	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000383	0.000425	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000379	0.00042	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—INS—polycystic ovary syndrome	0.000377	0.000418	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000376	0.000416	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000366	0.000406	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000365	0.000404	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000365	0.000404	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—AKT2—polycystic ovary syndrome	0.000365	0.000404	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000362	0.000401	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PRL—polycystic ovary syndrome	0.000361	0.0004	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000348	0.000386	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000347	0.000384	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000345	0.000382	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000344	0.000381	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000343	0.00038	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000331	0.000367	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000326	0.000361	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000318	0.000352	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000303	0.000335	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000302	0.000335	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000297	0.000329	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000288	0.000319	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000283	0.000313	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000255	0.000282	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—LEP—polycystic ovary syndrome	0.000249	0.000276	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000242	0.000268	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000238	0.000264	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—LEP—polycystic ovary syndrome	0.000237	0.000263	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000222	0.000246	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—POMC—polycystic ovary syndrome	0.000214	0.000237	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—INS—polycystic ovary syndrome	0.000213	0.000236	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000211	0.000234	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000206	0.000228	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000206	0.000228	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—POMC—polycystic ovary syndrome	0.000204	0.000226	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—INS—polycystic ovary syndrome	0.000202	0.000224	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000196	0.000217	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000196	0.000217	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000195	0.000217	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000186	0.000206	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—IL6—polycystic ovary syndrome	0.000165	0.000183	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000157	0.000174	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00015	0.000166	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000134	0.000149	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000128	0.000142	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL6—polycystic ovary syndrome	9.3e-05	0.000103	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL6—polycystic ovary syndrome	8.85e-05	9.8e-05	CbGpPWpGaD
